Combination of WEE1 Inhibitor and Vitamin K2 Enhances Therapeutic Efficacy in Chronic Myeloid Leukemia
The results suggest that a combination of MK-1775 and VK2 represents a potentially effective treatment strategy for CML, especially in drug-resistant cases.
Authors
- Daigo Akahane (ORCID: https://orcid.org/0000-0002-9295-1465)
- Seiichi Okabe (ORCID: https://orcid.org/0000-0002-2727-658X)
- Akihiko Gotoh (ORCID: https://orcid.org/0000-0002-8608-4393)
- Yuya Arai
Institutions
- Tokyo Medical University (JP)
Publication Details
- Journal
- Cancer Innovation
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1002/cai2.70024
- Citations
- 1
- Primary Topic
- Nuclear Receptors and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.91